Benjamin DAMIEN | CEO
Sagitta Biotech

Benjamin has obtained his PHD in Immunology from the University of Liège, and a MBA from Solvay Business School (Brussels). After a few years in academic research, in Europe and in the USA, he transitioned to the Biotech industry.

For the last 23 years, Benjamin has been mostly active within Biotech startups, as CEO, CSO or COO.
He is the founder and the CEO of Sagitta Biotech, a company developing next-generation targeted viral vectors of Oncology, Autoimmunity and Infectious diseases.